September 10, 2015 UTHSC Hamilton Eye Institute, Freeman Auditorium 12:00 PM – 1:00 PM (lunch is provided) RSVP to Tinieka Thrailkill | 901- 448-7827 Since 2012, UTHSC faculty have launched 10 new life science startup companies. At this workshop, you will hear directly from UTHSC faculty entrepreneurs about the challenges and successes they’ve had launching (read more)
UTHSC
GTx and UTRF Enter Into Exclusive License Agreement
GTx And UTRF Enter Into Exclusive License Agreement To Develop SARD Drug Candidate To Treat Castration-Resistant Prostate Cancer
Memphis-based device Company Receives $4.6 Million Investment
A Memphis-based device company has received a $4.6 million investment for its latest product. Ariste Medical has received the funding to continue development of a drug-eluting hernia mesh intended to reduce the risk of intra-abdominal infection. After hernia surgery, the risk of infection ranges from 8 percent to 40 percent, depending on complexity of the case.